Introduction
Type 1 diabetes mellitus (T1DM) is a disease caused by an autoimmune destruction of b-cells, and is clinically manifest when almost 90% of pancreatic islet b-cells are destroyed [1, 2] . It is a T-cell -mediated disease caused predominantly by CD4 positive cells. Islet cell antibodies (ICA), glutamic acid-decarboxylase (GAD65) antibodies, and insulin auto antibodies (IAA) are positive at diagnosis in over 85 % of Western T1DM patients [3] [4] [5] [6] [7] . The incidence of T1DM is growing at a rate of 3-5% every year [8, 9] . Of the world wide estimate of 490,000 children with T1DM, 24% are in the European region and 23% in the South East Asian region [10] . There are an estimated prevalence of 97,700 children with T1DM in India with an annual incidence of 3 new patients with T1DM per 100,000 children over a period of 13 years from 1995 to 2008 in the age group 0-16 years. Patients from India account for most of the pediatric prevalence of T1DM in South East Asia [11] . It has been hypothesized that environmental and microbial factors play a role in the rising incidence of T1DM [12] . Alterations in the composition of the enterobiome have been experimentally linked with the development of T1DM. In Non-Obese Diabetic (NOD) mice, a standard model of T1DM, the males have a lower incidence of T1DM than females. If the enterobiome of the male is altered to the female pattern, the incidence of T1DM rises to the female rate [13] [14] [15] [16] .
Historically, more than 40% of T1DM patients in India were antibody negative [17] . There are no significant studies from India tracing the change in auto-antibody positivity in recently diagnosed T1DM. We wanted to determine whether the antibody positivity of newly diagnosed T1DM children patients have changed since 2007, i.e. since the time we have been performing antibody measurements.
Materials and methods
The current study was a retrospective study, performed in two secondary referral endocrine clinics. The protocol was presented to the Ethics Committees of the two centers who felt that given the retrospective chart review nature of the study, informed consent is not neccesary We used plasma blood glucose rather than A1C to diagnose the acute onset of type 1 diabetes in individuals with symptoms of hyperglycemia. Patients with DKA and typical clinical features of T1DM as per the American Diabetes Association (ADA) position statement of 2017 and aged 1-16 years were included in the study [18] . In this retrospective chart review, we have only included patients with a confirmed diagnosis of type 1 diabetes, diagnosed by standard clinical criteria advocated by American Diabetes Association. All our patients had confirmed diagnosis of diabetic ketoacidosis (DKA) along with ketonuria. This finding strengthened the clinical diagnosis of T1DM in our patients and ensured that young type 2 diabetes patients were excluded.
Patients with pancreatitis, any feature suggestive of type 2 diabetes (T2DM), and diabetes from secondary causes were excluded from the study. Neonatal diabetes was excluded by age as the lower age limit for inclusion in the study is one year. Patient records meeting the eligibility criteria were evaluated from January 2007 to 31 st August 2016. Blood samples were collected for estimation of glucose, C-peptide, GAD and IA-2 autoantibody in all patients. Venous blood sampling was done once the acute metabolic crisis was over and before oral feeding was allowed, in one center and after discharge in the other center. Lipemic or grossly haemolysed samples were discarded and the test repeated. The kits used came from the same manufacturer all through and the tests were done in one center. Antibodies to glutamic acid decarboxylase (GAD) and insulinoma antigen-2 were measured in all newly diagnosed T1DM patients' (n = 692). Serum C-peptide values were required to be below the reference range. The samples were centrifuged at 2000 r.p.m. (at room temperature) for 15 min to separate the plasma. Plasma was decomplemented by heating at 56°C for 30 min and stored in aliquots at -20° C with 0.1% sodium azide as preservative. Serum GAD-Ab and IA-2 Ab titers were measured by I 125 RIA technique (DLD DI-AGNOSTIKA, GmBH, GERMANY) and C-peptide was estimated by RIA (IMMUNOTECH, FRANCE) [19] . For GAD and IA-2 antibody a titer ≤ 1.0 U/ml was considered normal while for C-peptide a fasting value ≥ 1.1 ng/ml was considered normal. Precision within the assay series was evaluated by processing 10 serum replicates. For GAD-Ab, IA-2Ab and C-peptide the results were mean 5.1 ± 0.96 U/ml (%CV 3.9), mean 3.6 ± 0.85 U/ml (%CV 2.7) and mean 1.05 ± 0.14 ng/ml (% CV 0.8) respectively. The assay sensitivities for GAD-Ab, IA-2Ab and C-peptide were 0.21 U/ml, 0.19 U/ml and 0.036 ng/ml respectively, as obtained from kit literature. It may be noted that the ADA does not advise measurement of C-peptide, thyroid function tests or screening for celiac disease during the initial metabolic crisis [20, 21] . This is because C-peptide values can be excessively depressed at this time, while thyroid function tests can be vitiated due to sick euthyroid syndrome and celiac screening affected by the lack of usual oral intake of gluten.
Statistical methods
Descriptive statistical analysis were carried out with SAS (Statistical Analysis System) version 9. 
Discussion
For reasons unknown, low rates of antibody positivity are found in T1DM patients in Asia in comparison to their Western counterparts [4] . Prevalence of 26 to 61% of antibody positivity in T1DM patients has been reported from North India [3, 5] . Tandon et al. have reported a 26% prevalence of GAD and/or IA-2Ab in T1DM patient with disease duration greater than 5 years in north India. They found a 14% GAD positivity and 15% IA-2Ab positivity [4] . Some other studies [4] have reported higher rates of antibody positivity. Overall, variable antibody positivity rates have been reported from India, but were substantially lower than the 85-95% GAD positivity reported in Western populations [15] [16] [17] .
Our study traced the autoantibody positivity of recently diagnosed T1DM patients over ten years in an East Indian pediatric population and found a secular trend of increased prevalence of antibody positivity (Table 1) . Similar results were demonstrated by Ahmed et al. in 2008 where the authors found a prevalence of 47% of auto antibodies in their T1DM population. GAD65 antibody was positive in 41.2% and IA-2 in 20.6%. A total of 14.7% TIDM subjects showed both GAD65 plus IA-2 autoantibody positivity [19] .
There is a rising incidence of T1DM worldwide, and global estimates show significant increases of 4.0% in Asia, 3.2% in Europe and 5.3% in North America. The average annual increase in incidence of T1DM was 2.4% (95% CI 1.3-3.4%) during 1990-1994, and a higher increase of 3.4% (95% CI 2.7-4.3%) was recorded in the period 1995-1999. There is a suggestion in the Indian literature that the incidence of T1DM has been raising in the recent years [22] . Around 78,000 children under 15 years of age are estimated to develop T1DM annually worldwide. An estimated 18,000 children under the age of 15 were newly diagnosed with T1DM in 2011 in India [23] . In south India, the Karnataka Type 1 Diabetes Registry reported an incidence of 3.7/100,000 in boys' and 4.0/100,000 in girls, over 13 years of data collection [23] . Recently Kalra et al. reported a high prevalence (10.20/100,000 population) of T1DM in Karnal district in north India [24] .
Wilkins had postulated an accelerator hypothesis where he linked weight gain with autoimmunity in T1DM in developed countries [25] . India being a fast developing country, has witnessed a rise in childhood obesity. Recently Jagadesan et al. had estimated 21.4% prevalence of childhood obesity among private school students in southern India [26] . Patterson and associates had further found a directly proportional relationship between national prosperity and childhood onset T1DM, which fits the data from India [27] . The hygiene hypothesis proposed by Gale and McKinney et al. which goes hand in hand with Patterson's hypothesis could also be one of the reasons for increases autoimmunity in our study sample [28, 29] . This recent surge in autoimmunity of T1DM could be triggered by a change in the enterobiome of the population. A decade ago, in an Indian study of newly diagnosed T1DM, 
Conclusion
Our study traces the autoantibody positivity of recently diagnosed T1DM children over past ten years in an East Indian population and found a significant increase of autoantibody positivity over time. As this was an observational retrospective study, we could not assign any definite cause to this increase in autoimmunity. This surge in autoimmunity may be a significant contributing factor towards the recent reported increased incidence of TIDM in India.
Limitations
We have not included ZnT8 in our analysis since it is recently added in the panel of auto-antibodies for screening of T1DM from 2012 onwards. Since, we have included T1DM patients diagnosed from the year 2007; we wanted to maintain uniformity of the tested antibody in the study. Hence the antibody ZnT8 was not tested.
